We are delighted to announce that we have successfully raised nearly £900,000 from both new and existing shareholders! This latest round of investment is a strong endorsement of our vision and mission, and we are deeply grateful for the trust and support of our investors.

This funding will play a pivotal role in accelerating the commercialization of the VSP Patch in the U.S. market. Our innovative solution is designed to empower clinicians, patients, and healthcare providers with cutting-edge neonatal monitoring technology, and this investment marks a significant step forward in making it widely accessible.

As we embark on this next phase of growth, we extend our heartfelt thanks to our dedicated team, partners, and supporters who have contributed to our success so far. Your belief in our mission fuels our drive to make a lasting impact in neonatal healthcare.

Stay tuned for further updates as we expand our reach and bring our innovative technology to more newborns and their families.